« « Shionogi Completes Acquisition of Sciele – MarketWatch 
|  MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes … – FOXBusiness » »
Amylin continues slide on diabetes drug concerns – Forbes
Friday, October 10th, 2008    Subscribe To Our Feed|
Amylin continues slide on diabetes drug concerns
Forbes,?NY?- 13 hours ago In all, the company and Food and Drug Administration have reported six deaths in patients who had taken the diabetes treatment. The reports sparked a stock … |
Source:Amylin continues slide on diabetes drug concerns – Forbes
No Tags
Posted in insulin | | Top Of Page
Site Search Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Possible Related Posts
Sector Snap: Diabetes treatment guidelines change – ForbesAmylin shares plunge on FDA study data rejection – ForbesAmylin shares recover on diabetes drug data – Forbes